Skip to main content

Rabbit Brain Concentrations of Doxorubicin During Intraarterial Infusions

  • Chapter
Neuro-Oncology

Part of the book series: Developments in Oncology ((DION,volume 66))

  • 85 Accesses

Abstract

This study was undertaken to evaluate hydrophilic antitumor agents administered in intraarterial (IA) infusions. Brain distributions of doxorubicin (Adriamycin, ADR) after IA infusions were determined in rabbit VX-2 brain tumor model. With right carotid infusions of ADR (8 rabbits), tumor center concentrations averaged 3.3 ± 1.42 μg/g (mean ± 1 SE), concentrations at least 100 times greater than in vitro inhibitory concentrations (IC50) of ADR for human gliomas. ADR concentrations in brain-around-tumor averaged 2.43 ± 0.81 μg/g, but were only 0.104 ± 0.019 μg/g in non-tumor-bearing hemisphere. In 15 rabbits with VX-2 brain tumors, carotid artery infusions of ADR increased mean survival times by 20.9 ± 8.3%. These findings are supported by animal study using IA infusions of ADR after hyperosmotic blood-brain barrier (BBB) disruption and study in brain tumor patients using IA infusions of ADR. These results show that significant amounts of relatively non-lipophilic drugs, with IA infusions, can penetrate brain tumor areas but still spare normal areas from toxic drug exposure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alley, M.C., Scudiero, D.A., Monks, A., et al. (1988) ‘Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay’, Cancer Res. 48, 589–601.

    PubMed  CAS  Google Scholar 

  2. Blum, R.H. and Carter, S.K. (1974) ‘Adriamycin. A new anticancer drug with significant clinical activity’, Ann. Intern. Med. 80, 249–259.

    PubMed  CAS  Google Scholar 

  3. Collins, J.M. (1984) ‘Pharmacologic rationale for regional drug delivery’, J. Clin. Oncol. 2, 498–504.

    PubMed  CAS  Google Scholar 

  4. Nakazawa, S., Itoh, Y., Shimura, T., et al. (1983) ‘New management of brain neoplasms’, No Shinkei Geka 11, 821–827.

    PubMed  CAS  Google Scholar 

  5. Neuwelt, E.A., Pagel, M., Barnett, P., et al. (1981) ‘Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification’, Cancer Res. 41, 4466–4470.

    PubMed  CAS  Google Scholar 

  6. Sakai, N., Kondo, H., Shikinami, A., et al. (1984) ‘Postoperative treatment for malignant intracranial tumors – especially concerning intermittent intra-carotid administration of adriamycin’, No Shinkei Geka 12(3 Suppl), 237–243.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hassenbusch, S.J. (1991). Rabbit Brain Concentrations of Doxorubicin During Intraarterial Infusions. In: Paoletti, P., Takakura, K., Walker, M.D., Butti, G., Pezzotta, S. (eds) Neuro-Oncology. Developments in Oncology, vol 66. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3152-0_39

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3152-0_39

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5390-7

  • Online ISBN: 978-94-011-3152-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics